Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11919958 Anti-CD28 compositions

Patent 11919958 was granted and assigned to Xencor on March, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Xencor
Xencor
0
Date Filed
August 19, 2021
0
Date of Patent
March 5, 2024
0
Patent Applicant
Xencor
Xencor
0
Patent Application Number
17407135
0
Patent Citations
‌
US Patent 7695936 Knobs and holes heteromeric polypeptides
0
‌
US Patent 6881557 Super humanized antibodies
0
‌
US Patent 6994853 Time-staggered utilization of tumor cells in combination with intact antibodies for immunization
0
‌
US Patent 7112324 CD 19×CD3 specific polypeptides and uses thereof
0
‌
US Patent 7538196 Bispecific antibody molecule
0
‌
US Patent 7642228 Method for making heteromultimeric polypeptides
0
‌
US Patent 8367805 Fc variants with altered binding to FcRn
0
‌
US Patent 8409568 Mutant antibody Fc domains and fusion proteins thereof
0
‌
US Patent 8592562 Method for making antibody Fc-heterodimeric molecules using electrostatic steering effects
0
‌
US Patent 8637641 Antibodies with modified isoelectric points
0
•••
Patent Inventor Names
Michael Hedvat
0
John R. Desjarlais
0
Juan Diaz
0
Veronica Gusti Zeng
0
Gregory Moore
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11919958
0
Patent Primary Examiner
‌
Adam Weidner
0
CPC Code
‌
C07K 16/2818
0
‌
C07K 2317/31
0
‌
C07K 2317/522
0
‌
C07K 2317/524
0
‌
C07K 2317/526
0
‌
C07K 2317/53
0
‌
C07K 2317/56
0
‌
C07K 2317/622
0
‌
C07K 16/2827
0

Find more entities like US Patent 11919958 Anti-CD28 compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.